A carregar...
Overcoming cancer cell resistance to VSV oncolysis with JAK1/2 inhibitors
Oncolytic vesicular stomatitis virus (VSV) has potent antitumor activity but some cancer cells are resistant to VSV killing, either constitutively or due to type I interferon (IFN) inducing an antiviral state in the cells. Here, we evaluated VSV oncolysis of a panel of human head and neck cancer cel...
Na minha lista:
| Publicado no: | Cancer Gene Ther |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4817541/ https://ncbi.nlm.nih.gov/pubmed/24030211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cgt.2013.55 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|